I vantaggi della correzione mininvasiva delle cardiopatie congenite riletti dopo 25 anni di esperienza

Author:

Cattapan Claudia1,Guariento Alvise1,Castaldi Biagio2,Sirico Domenico2,Scattolin Fabio1,Padalino Massimo1,Di Salvo Giovanni2,Vida Vladimiro1

Affiliation:

1. UOC di Cardiochirurgia Pediatrica e Cardiopatie Congenite, Università di Padova

2. UOC di Cardiologia Pediatrica, Università di Padova

Abstract

Background - For many years the treatment of congenital heart disease has been performed through median sternotomy. Recently, the dimensions of the cutaneous incision have been reduced to optimize functional recovery and improve the aesthetic result. However, there are still few experiences in this field. Objectives - The objective of the study is to describe the results of minimally invasive cardiac surgery at the Paediatric Cardiac Surgery Unit of the Hospital-University of Padua in over 25 years of experience. Materials and Methods - The study included all paediatric patients who underwent minimally invasive cardiac surgery (ministernotomy, right anterior minithoracotomy, or right lateral minithoracotomy) between January 1998 and December 2022. Intraoperative and early postoperative (during hospitalization) outcomes were investigated. Results - All patients (1,111) underwent a successful correction, without any need for conversion to median sternotomy. The median length of stay in the intensive care unit was 1 day (1-2 days), and in the hospital was 5 days (4-6 days). There were no in-hospital deaths and the rate of major complication was 3% (33/1,111 patients). Conclusions - The treatment of congenital heart disease with minimally invasive cardiac surgery when performed in experienced centres shows excellent clinical results without any additional risk compared to the traditional median sternotomy. For this reason, minimally invasive cardiac surgery has been the gold standard for the treatment of many congenital heart diseases for over 25 years.

Publisher

Medico e Bambino

Subject

Microbiology (medical),Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3